Fluorescent in situ hybridization analysis of Philadelphia chromosome-negative chronic myeloid leukemia with the bcr/abl fusion gene

International Journal of Hematology

Volumn 80, Issue 2, 2004, Pages 155-158

  Monma, Fumihiko ^a   Nishii, Kazuhiro ^a   Yamamori, Shunji ^b   Hosokai, Noboru ^b   Nakazaki, Takahiro ^c   Lorenzo V, Felipe ^a   Usui, Eiji ^a   Sakakura, Miho ^a   Miyashita, Hiroyuki ^a   Fujieda, Atsushi ^a   Ohishi, Kohshi ^a   Katayama, Naoyuki ^a   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Mitsubishi Kagaku Bio Clinical Laboratories Inc   (Japan)

^c Takeuchi Hospital   (Japan)

Author keywords

CML; FISH; Imatinib; Masked Ph; Ph negative CML; Philadelphia chromosome; t(9; 22)

Indexed keywords

BCR ABL PROTEIN;

ADULT; ARTICLE; BCR ABL FUSION GENE; CASE REPORT; CHROMOSOME 22; CHRONIC MYELOID LEUKEMIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE INSERTION; HUMAN; HUMAN CELL; KARYOTYPING; PHILADELPHIA 1 CHROMOSOME;

ADULT; FEMALE; GENES, ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID, PHILADELPHIA-NEGATIVE; METAPHASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 4444297878     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04007     Document Type: Article

References (19)

1. Cortes JE, Talpaz M, Beran M, et al. Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region: long term follow-up results. Cancer. 1995;75:464-470.
2. Takahashi N, Miura I, Ohshima A, et al. Duplication of chromosome 9 carrying a BCR/ABL chimeric gene in Philadelphia chromosome negative chronic myeloid leukemia. Cancer Genet Cytogenet. 1996;89:166-169.
3. Kurzrock R, Blick MD, Talpaz M, et al. Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia. Ann Intern Med. 1986; 105:673-679.
4. van der Plas DC, Hermans ABC, Soekarman D, et al. Cytogenetic and molecular analysis in Philadelphia negative CML. Blood. 1989; 73:1038-1044.
5. Goldman JM, Melo JV. Chronic myeloid leukemia: advances in biology and new approaches to treatment. N Engl J Med. 2003;349: 1451-1464.
6. Weinstein ME, Grossman A, Perle MA, et al. The karyotype of Philadelphia chromosome-negative, her rearrangement-positive chronic myeloid leukemia. Cancer Genet Cytogenet. 1988;35: 223-229.
7. Calabrese G, Stuppia M, Franchi PG, et al. Complex translocation of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis. Cancer Genet Cytogenet. 1994;78:153-159.
8. Hagemeijer A, Buijs A, Smit E, et al. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia. Genes Chromosomes Cancer. 1993;8:237-245.
9. Inazawa J, Nishigaki H, Takahira H, et al. Rejoining between 9q+ and Philadelphia chromosomes results in normal-looking chromosomes 9 and 22 in Ph-negative chronic myelocytic leukemia. Hum Genet. 1989;83:115-118.
10. Morris CM, Heisterkamp N, Kennedy MA, Fitzgerald PH, Groffen J. Ph-negative chronic myeloid leukemia: molecular analysis of ABL insertion into M-BCR on chromosome 22. Blood. 1990;76: 1812-1818.
11. Tanaka K, Minamihisamatu M, Yagi S, et al. Two step mechanism for formation of complex 9;22 chromosome translocation in chronic myelocytic leukemia detected by fluorescence in situ hybridization. Exp Oncol. 2001;23:29-38.
12. Sokal JE, Cox EB, Baccarani M, et al. Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood. 1984;63: 789-799.
13. Hasford J, Pfirrmann M, Hehlmann R, et al. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa: Writing Committee for the Collaborative CML Prognostic Factors Project Group. J Natl Cancer Inst. 1998;90:850-858.
14. Kantarjian HM, Keating MJ, Smith TL, Talpaz M, McCredie KB. Proposal for simple synthesis prognostic staging system in chronic myelogenous leukemia. Am J Med. 1990;88:1-8.
15. Nishii K, Usui E, Sakakura M, et al. Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia. Cancer Genet Cytogenet. 2001;126:8-12.
16. Talpaz M, Kantarjian HM, Kurzrock R.Trujillo JM, Gutterman JU. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia: Philadelphia chromosome-positive patients. Ann Intern Med. 1991;114:532-538.
17. El-Zimaity MMT, Kantarjian HM, Talpaz M, et al. Results of imatinib mesylate therapy in chronic myelogenous leukemia with variant Philadelphia chromosome. Br J Haematol. 2004;125:187-195.
18. Nishii K, Usui E, Katayama N, et al. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML. Leukemia. 2003;17:731-737.
19. Osumi K, Fukui T, Kiyoi H, et al. Rapid screening of leukemia fusion transcripts in acute leukemia by real-time PCR. Leuk Lymphoma. 2002;43:2291-2299.